Yu-Tung Wu

Yu-Tung Wu

Auto-generated profile, based on publicly available information

Yu-Tung Wu

Department of Trauma and Emergency Surgery, Chang Gung Memorial Hospital Linkou, Taoyuan, Taiwan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2019 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
CCChang-Hua Chou
Chang-Hua Chou
YWYu-Tung Wu
Yu-Tung Wu
CFChih-Yuan Fu
Chih-Yuan Fu
CLChien-Hung Liao
Chien-Hung Liao
Shang Yu WangShang Yu Wang
Shang Yu Wang
CHChiHsun Hsieh
ChiHsun Hsieh
While transcatheter arterial embolization (TAE) is an effective way to control arterial bleeding associated with pelvic fracture, delayed TAE may increase mortality risk. The purpose of the current study was to determine how time to TAE affects outcomes in patients with pelvic fracture in the emergency department. From January 2014 to December 2016, the trauma registry and medical records of patients with pelvic fracture who underwent TAE were retrospectively reviewed. The relationship between the time to TAE and patient outcomes was evaluated. The characteristics of surviving and deceased patients were also compared to search for prognostic factors affecting survival. Eighty-four patients were enrolled in the current study. Among patients with pelvic fracture who underwent TAE, the overall mortality rate was 16.7%. There were positive relationships between the time to TAE and the requirement for blood transfusion and between the time to TAE and intensive care unit (ICU) length of stay (LOS). Nonsurviving patients were significantly older (57.4 ± 23.3 vs. 42.7 ± 19.3 years old, p = 0.014) and had higher injury severity scores (ISSs) (36.4 ± 11.9 vs. 23.9 ± 10.9, p < 0.001) than were observed in surviving patients. There was no significant difference in the time to TAE between nonsurviving and surviving patients (76.9 ± 47.9 vs. 59.0 ± 29.3 min, p = 0.068). The multivariate logistic regression analysis showed that ISS and age served as independent risk factors for mortality. Every one unit increase in ISS or age resulted in a 1.154- or 1.140-fold increase in mortality, respectively (p = 0.033 and 0.005, respectively). However, the time to TAE serves as an independent factor for ICU LOS (p = 0.015). In pelvic fracture patients who require TAE for hemostasis, longer time to TAE may cause harm. An early hemorrhage control is suggested.

28 August 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ChienHung LiaoChienHung Liao
ChienHung Liao
YWYu-Tung Wu
Yu-Tung Wu
Chi-Tung ChengChi-Tung Cheng
Chi-Tung Cheng
OCOuyang Chunghsiang
Ouyang Chunghsiang
SKShih-Ching Kang
Shih-Ching Kang
CCChih-Chi Chen
Chih-Chi Chen
Background: The application of mobile health (mHealth) platforms to monitor recovery in the postdischarge period has increased in recent years. Despite widespread enthusiasm for mHealth, few studies have evaluated the usability and user experience of mHealth in patients with surgical drainage. Objective: Our objectives were to (1) develop an image-based smartphone app, SurgCare, for postdrainage monitoring and (2) determine the feasibility and clinical value of the use of SurgCare by patients with drainage. Methods: We enrolled 80 patients with biliary or peritoneal drainage in this study. A total of 50 patients were assigned to the SurgCare group, who recorded drainage monitoring data with the smartphone app; and 30 patients who manually recorded the data were assigned to the conventional group. The patients continued to record data until drain removal. The primary aim was to validate feasibility for the user, which was defined as the proportion of patients using each element of the system. Moreover, the secondary aim was to evaluate the association of compliance with SurgCare and the occurrence of unexpected events. Results: The average submission duration was 14.98 days, and the overall daily submission rate was 84.2%. The average system usability scale was 83.7 (SD 3.5). This system met the definition of “definitely feasible” in 34 patients, “possibly feasible” in 10 patients, and “not feasible” in 3 patients. We found that the occurrence rates of complications in the SurgCare group and the conventional group were 6% and 26%, respectively, with statistically significant differences P=.03. The rate of unexpected hospital return was lower in the SurgCare group (6%) than in the conventional groups (26%) (P=.03). Conclusions: Patients can learn to use a smartphone app for postdischarge drainage monitoring with high levels of user satisfaction. We also identified a high degree of compliance with app-based drainage-recording design features, which is an aspect of mHealth that can improve surgical care.

4 January 2025 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
PDF file
YCYauRen Chang
YauRen Chang
YWYu-Tung Wu
Yu-Tung Wu
SCSzu An Chen
Szu An Chen
CFChih-Yuan Fu
Chih-Yuan Fu
Chi-Tung ChengChi-Tung Cheng
Chi-Tung Cheng
CHChiHsun Hsieh
ChiHsun Hsieh
Introduction: Pelvic fractures often result in life-threatening bleeding and hemodynamic instability. Resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as a promising strategy for patients with severe pelvic fractures, facilitating subsequent hemostatic interventions. Transcatheter arterial embolization (TAE) is a well-established procedure for managing pelvic fractures accompanied by hemorrhage. Ideally, an angiographic access point distinct from the initial REBOA placement is sought to maintain REBOA deflation without complete removal, thereby preventing hemodynamic instability during the procedure. However, in cases of extreme and severe pelvic trauma, gaining access for REBOA is already challenging, not to mention the additional difficulty posed by subsequent angiographic access. This study aims to assess the challenges associated with gaining access in cases where successful TAE was ultimately performed, particularly in the context of severe pelvic trauma. We investigate the complexities surrounding access management and its implications for patient outcomes. Methods: We conducted a retrospective analysis of patients who presented with pelvic fractures and underwent sequential REBOA and TAE procedures at our institution between 2017 and 2023. We excluded patients with Abbreviated Injury Scores (AIS) ≥3 in systems other than the pelvis, those who underwent TAE prior to REBOA, and cases of suboptimal REBOA insertion. We collected demographic data, injury characteristics, details of the REBOA and TAE procedures, information on complications, and data on patient survival. The primary endpoints of our analysis included overall survival and the success of TAE (defined as post TAE mean arterial pressure (MAP) ≥65 mm Hg). Secondary endpoints encompassed the duration details of two interventions. Results: Between 2017 and 2023, a total of 17 patients were included in this study. Among this cohort, 12 (70.6%) were male, with a median age of 51 years. Overall survival was 23.5%. Patients were grouped into angiography after REBOA deflation (AAD) or angiography after REBOA removal (AAR). AAR group was younger (39.0 vs 63.0, p=0.030) and had higher Shock Index at triage (2.30 vs 1.10, p=0.015). More patient whose post TAE MAP >=65 mm Hg was found in the AAR group, although no significant difference on overall survival (25.0% vs 22.2%, p=1.000). Angiographic cannulation times, pre-angiographic MAP, and amount of pre-angiographic transfusion of packed red blood cell were similar across groups. Conclusion: Our findings provide empirical insights into vascular access selection and suggest that AAR in the management of severe pelvic fractures can be beneficial, particularly when pre-angiographic resuscitation is sufficient. Larger studies are required to validate these observations and assess long-term outcomes. Level of evidence: III.

13 January 2026 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
YWYu-Tung Wu
Yu-Tung Wu
SPStephen Park
Stephen Park
JLJoy Li
Joy Li
ETEmiliano Tabarsi
Emiliano Tabarsi
MSMorgan Schellenberg
Morgan Schellenberg
KMKazuhide Matsushima
Kazuhide Matsushima
Background: The “surgical soul” indicates a small spherical area at the head of pancreas with adjacent major vessels. Traumatic injuries to this area are known for the extreme complexity to manage. The aim of this study was to describe the characteristics and outcomes of patients with wounded surgical soul using a nationwide dataset. Methods: We conducted a retrospective cohort study using the American College of Surgeons Trauma Quality Improvement Program database (2013–2018). We included patients (age ≥16 years) with Abbreviated Injury Scale (AIS) ≥4 pancreatic and/or duodenal injuries with associated injuries to any of the following vessels: inferior vena cava (IVC), superior mesenteric artery/vein injury (SMA/SMV), portal vein (PV), renal vein (RV), and splenic vein (SV). Multivariate logistic regression was performed to identify factors associated with in-hospital mortality. Results: A total of 219 patients were identified. Of those, 178 (81.3%) sustained penetrating trauma. Pancreatic injury accounted for 73.5% of all patients, 39.8% with duodenal injury, 45.2% with IVC injury, 11.0% with SMA injury, and 56.6% with PV/SMV/RV/SV injury. Liver (56.2%), colon (47.0%), and stomach (37.9%) were common associated injuries. The overall in-hospital mortality rate was 58% with most deaths occurring <48 hours. In the multivariate analysis, older age, systolic blood pressure 3, abdominal aortic injury, and packed red blood cell transfusion >10 units within 24 hours were factors associated with mortality. Conclusions: Injuries to the surgical soul are rare but associated with a significant mortality risk. The surgical strategy should focus on early hemorrhage control to improve the likelihood of patient survival. Level of evidence: Prognostic/epidemiological, level IV.

1 January 2026 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
YWYutung Wu
Yutung Wu
JGJohn Peter Gruen
John Peter Gruen
KMKazuhide Matsushima
Kazuhide Matsushima
MSMorgan Schellenberg
Morgan Schellenberg
KIKenji Inaba
Kenji Inaba
MMMatthew J Martin
Matthew J Martin
Background: Timely initiation of venous thromboembolism prophylaxis (VTEp) has been known to decrease venous thromboembolism (VTE after trauma; however, early VTEp in patients undergoing neurosurgical interventions (NSIs) is controversial with conflicting reports in the literature from retrospective studies. We aimed to evaluate the safety and outcomes of early VTEp in this high-risk cohort. Methods: The study was a secondary analysis from the prospective multicenter Consortium of Leaders in the Study of Traumatic Thromboembolism database. Traumatic brain injury (TBI) patients receiving NSI were included. Patients were divided into early (≤72 hours) and late (>72 hours) VTEp groups. Mortality, VTE, deep vein thrombosis (DVT), pulmonary embolism, and bleeding adverse events including progression of intracranial hemorrhage (pICH) were compared. Results: Among the total 238 patients, 233 (97.9%) underwent craniotomy or craniectomy, and 140 (58.8%) received early VTEp. Patients with a head Abbreviated Injury Scale score of 5 and craniectomy were more likely to delay VTEp (>72 hours) (all p<0.05). Compared with late VTEp, early VTEp exhibited lower rates of VTE (10.7% vs 16.3%, p=0.28) and DVT (8.6% vs 15.3%, p=0.16), though without achieving statistical significance. Through generalized estimating equation and competing risk analysis, early VTEp did not demonstrate a significant decrease of VTE risk (OR) 0.74, 95% CI 0.33 to 1.67; HR 0.90, 95% CI 0.45 to 1.84), whereas the risk of adverse bleeding events (OR 0.79, 95% CI 0.24 to 2.57) or pICH (OR 1.10, 95% CI 0.30 to 4.03) did not increase with early VTEp either. Conclusion: Early VTEp is not significantly associated with reduced rates of VTE or DVT in patients with severe TBI requiring emergent NSI, but it also does not increase the risk of adverse bleeding event or pICH. Level of evidence: Level IV; therapeutic/care management.

3 June 2023 in Surgery
Verified
Journal Article
Closed access
TJTyler J. Johnston
Tyler J. Johnston
IHIan F. Hulsebos
Ian F. Hulsebos
PBPhillip A. Bonney
Phillip A. Bonney
YWYu-Tung Wu
Yu-Tung Wu
CGCameron A. Ghafil
Cameron A. Ghafil
KMKazuhide Matsushima
Kazuhide Matsushima